-+ 0.00%
-+ 0.00%
-+ 0.00%

MODERNA ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 CLINICAL TRIAL EVALUATING INVESTIGATIONAL TUMOR-TARGETED CANCER ANTIGEN THERAPY IN SOLID TUMORS

Reuters·07/16/2026 11:39:30

Please log in to view news